Waud Capital Partners didn’t choose medical device and supply chain services randomly for its $100+ million partnership with Bill Mixon. The Chicago-based firm has spent years building expertise across healthcare supply chains through investments in companies like Mopec Group, PromptCare, and DS Medical, creating natural synergies for new platform development. Founder Reeve Waud’s systematic approach to sector development establishes knowledge bases and operational capabilities that inform subsequent platform investments.
The partnership builds upon what Kyle Lattner described as Waud Capital’s “extensive experience investing across the broader healthcare supply chain services and home care markets.” This accumulated expertise creates competitive advantages for the Mixon platform, from understanding market dynamics to identifying acquisition opportunities and implementing operational improvements across related healthcare infrastructure sectors.
Existing Healthcare Supply Chain Assets
Waud Capital Partners’ current healthcare supply chain investments span multiple segments that complement the targeted areas for the Mixon platform. Mopec Group serves as a supplier of pathology equipment, consumables and services, providing insight into medical equipment distribution and specialty healthcare markets. PromptCare operates in home infusion and durable medical equipment, offering experience with direct-to-patient delivery systems and insurance coordination.
Provider Network Holdings focuses on specialty medication supply management, creating understanding of complex healthcare supply chains and regulatory requirements. DS Medical handles home medical supplies, providing operational knowledge about patient service models and logistics systems. Each investment addresses different segments of healthcare supply chain services while building institutional knowledge about market conditions and operational requirements.
The portfolio investments create potential cross-platform opportunities through shared customer bases, overlapping service areas, and complementary capabilities. Healthcare providers often source supplies, equipment, and services from multiple vendors, creating opportunities for integrated service delivery and operational efficiency improvements.
Reeve Waud’s approach to building related portfolio companies enables knowledge transfer and best practice sharing across investments. Lessons learned from successful operational improvements at one company inform strategies at other portfolio companies, accelerating value creation and reducing implementation risks.
Home Care Platform Development
Waud Capital Partners has developed significant expertise in home care markets through recent investments including AltoCare (in-home senior care) and Concierge Home Care (skilled home healthcare). These platforms provide understanding of home-based service delivery models, patient engagement systems, and regulatory compliance requirements that extend to medical device and supply chain services.
The home care experience creates synergies with Mixon’s background in home distribution services and chronic care management. Advanced Diabetes Supply’s growth to serve 500,000 patients annually required sophisticated direct-to-patient delivery systems and clinical support capabilities that complement home care service models.
Home care and medical supply services often serve overlapping patient populations, particularly in chronic disease management and post-acute care. The combination creates opportunities for coordinated service delivery and improved patient outcomes through integrated care models.
Steve Jakubcanin’s partnership with Waud Capital Partners to pursue home care and post-acute services platforms demonstrates the firm’s systematic approach to executive partnerships in related sectors. The Jakubcanin and Mixon partnerships create potential operational synergies and knowledge sharing opportunities across complementary healthcare service platforms.
Operational Knowledge Transfer
Waud Capital Partners’ healthcare portfolio provides operational templates for building successful medical device and supply chain platforms. The firm’s experience with healthcare services acquisitions, integration strategies, and operational improvements creates institutional knowledge that accelerates new platform development.
Mike Lehman’s involvement across multiple healthcare deals provides continuity and sector expertise for the Mixon partnership. His description of healthcare supply chain markets as “highly fragmented with significant opportunities for organizations to deliver value-add solutions” reflects accumulated market knowledge from managing related portfolio investments.
The portfolio companies provide case studies for successful healthcare consolidation strategies, operational improvement initiatives, and exit opportunities. Reeve Waud’s experience building Acadia Healthcare from startup to public company establishes methodologies for platform development that apply across different healthcare sectors.
Recent successful exits, including the $2.2 billion GI Alliance recapitalization, demonstrate the firm’s capability to create value and achieve attractive exit opportunities in healthcare services markets. These experiences inform current investment strategies and provide confidence for substantial capital commitments like the Mixon partnership.
Related: How Chicago Companies Are Rethinking Office Strategy for Hybrid Work
Strategic Market Positioning
The combined healthcare portfolio positions Waud Capital Partners to capitalize on broader industry trends favoring consolidation in healthcare support services. As healthcare delivery becomes more complex and regulated, providers increasingly rely on specialized service companies for supply chain management, equipment services, and patient support functions.
The portfolio creates potential for integrated service delivery across multiple healthcare infrastructure segments. Combinations of supply chain services, home care, and specialty distribution can offer healthcare providers more comprehensive solutions while achieving operational efficiencies through shared systems and resources.
Kyle Lattner noted this represents “our second dedicated campaign in the medical device and supply chain services market in the last two years,” indicating sustained institutional focus on healthcare infrastructure consolidation. Multiple campaigns in related sectors suggest systematic market development rather than opportunistic investments.
The accumulated healthcare expertise enables more sophisticated platform development strategies and operational improvement initiatives. Reeve Waud’s three-decade focus on healthcare consolidation has created institutional capabilities that extend beyond capital provision to include sector knowledge, operational expertise, and strategic insights that accelerate platform development and value creation across targeted healthcare infrastructure markets.
More news: Waud Capital unveils latest growth-oriented buyout fund, targets $1bn